Waddell & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Buy |
1,960
+7
| +0.4% | +$1.3K | 0.04% | 145 |
|
|
2025
Q1 | $409K | Sell |
1,953
-10
| -0.5% | -$2.1K | 0.05% | 100 |
|
|
2024
Q4 | $349K | Sell |
1,963
-59
| -3% | -$10.5K | 0.04% | 112 |
|
|
2024
Q3 | $399K | Buy |
2,022
+67
| +3% | +$13.2K | 0.05% | 95 |
|
|
2024
Q2 | $335K | Buy |
1,955
+75
| +4% | +$12.9K | 0.04% | 98 |
|
|
2024
Q1 | $342K | Sell |
1,880
-1,988
| -51% | -$362K | 0.05% | 97 |
|
|
2023
Q4 | $597K | Sell |
3,868
-239
| -6% | -$36.9K | 0.08% | 69 |
|
|
2023
Q3 | $612K | Sell |
4,107
-99
| -2% | -$14.8K | 0.09% | 68 |
|
|
2023
Q2 | $567K | Sell |
4,206
-340
| -7% | -$45.8K | 0.08% | 69 |
|
|
2023
Q1 | $724K | Sell |
4,546
-1,699
| -27% | -$271K | 0.11% | 60 |
|
|
2022
Q4 | $1.01M | Buy |
6,245
+620
| +11% | +$100K | 0.17% | 45 |
|
|
2022
Q3 | $755K | Sell |
5,625
-89
| -2% | -$11.9K | 0.15% | 49 |
|
|
2022
Q2 | $875K | Buy |
5,714
+1,935
| +51% | +$296K | 0.18% | 46 |
|
|
2022
Q1 | $613K | Sell |
3,779
-1,140
| -23% | -$185K | 0.1% | 57 |
|
|
2021
Q4 | $666K | Buy |
4,919
+53
| +1% | +$7.18K | 0.11% | 56 |
|
|
2021
Q3 | $525K | Buy |
4,866
+200
| +4% | +$21.6K | 0.09% | 61 |
|
|
2021
Q2 | $526 | Buy |
+4,666
| New | +$526 | 0.08% | 60 |
|